The VICTORIA Study (Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation) Comparison Anti-vitamin K Versus Anti-Xa.
Phase of Trial: Phase IV
Latest Information Update: 08 Nov 2019
Price : $35 *
At a glance
- Drugs Rivaroxaban (Primary) ; Fluindione; Warfarin
- Indications Atherosclerosis; Thrombosis
- Focus Therapeutic Use
- Acronyms VICTORIA
- 05 Nov 2019 Status changed from recruiting to completed.
- 24 Jul 2014 New trial record